CSPC Pharmaceutical Group (HKSE:01093) Net Change in Cash : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

CSPC Pharmaceutical Group's Net Change in Cash for the three months ended in Dec. 2023 was HK$0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0 Mil.

CSPC Pharmaceutical Group Net Change in Cash Historical Data

The historical data trend for CSPC Pharmaceutical Group's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Net Change in Cash Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-241.89

3,723.71

2,204.35

-1,182.44

2,723.50

CSPC Pharmaceutical Group Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															-	-	-	-	-

CSPC Pharmaceutical Group Net Change in Cash Calculation

CSPC Pharmaceutical Group's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	4570.7	+	664.216	+	-2516.764	+	5.351
	=	2,724

CSPC Pharmaceutical Group's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 0 + 0 + 0 + 0

= 0

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group Net Change in Cash Related Terms
Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (HKSE:01093) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Net Change in Cash

Comparable Companies

HKSE:01666 HKSE:01643 LLY JNJ MRK ABBV LSE:AZN XSWX:NOVN XSWX:ROG AMGN PFE XPAR:SAN BMY LSE:GSK GILD TSE:4568 TSE:4519 SHSE:600276 BIIB XTER:BAYN

Traded in Other Exchanges

CSPCY:USA CHJTF:USA CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (HKSE:01093) Headlines

No Headlines